Mohammed Eslam is a Hepatologist based in Westmead, NSW. His clinic address is 176 Hawkesbury Rd, Westmead, NSW 2145, Australia.
Dr Eslam looks after people with liver conditions and the health problems that can come with them. This can include fatty liver disease, NASH (non-alcoholic steatohepatitis), and cirrhosis. He also works with patients who have hepatitis, including hepatitis A, B, and C, as well as hepatitis D.
Many people who come in have long-term changes to the liver, or symptoms linked to liver scarring. At times, this may include issues like portal hypertension, esophageal varices, and gastrointestinal bleeding. He also helps manage liver failure and severe complications where the liver is struggling to work properly.
Metabolic health is a big part of liver care for many patients. Dr Eslam supports people with metabolic syndrome, obesity, and type 2 diabetes, especially when these are tied to liver fat and liver inflammation. Alcohol-related liver disease is also part of his clinical work, including alcoholic cirrhosis.
Some conditions need extra care because they are less common. His work covers things like alpha-1 antitrypsin deficiency (AATD), Cryoglobulinemia, and congenital hyperinsulinism. He also cares for people with liver cancer, and he may support patients through the complex pathway that can include liver transplant care.
There are other health topics that can affect the liver too. His practice includes care related to hairly cell leukemia (HCL), and lung-related problems like pneumonia and, in some cases, severe viral illnesses such as COVID-19 and SARS. He also looks at rarer issues like hiatal hernia and subcutaneous emphysema when they show up alongside broader health concerns.
In many cases, the goal is clear and practical: get the diagnosis right, manage symptoms, and help people plan what to do next. Dr Eslam’s approach focuses on ongoing liver care across a range of patient needs, from early work-ups to serious long-term management.
Education details, research output, and clinical trial involvement weren’t listed in the available information.